Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s … – Endpoints News
|
Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead's …
Endpoints News Spark Therapeutics $ONCE has recruited Federico Mingozzi, a noted gene therapy expert at INSERM and Genethon in France, as chief scientific officer. Mingozzi picked up his PhD at the University of Ferrara, Italy and an MBA from Drexel University in … |
